R-split-EPOCH plus high dose methotrexate in untreated diffuse large B cell lymphoma with MYC rearrangement or double expression of MYC and BCL-2

Purpose: Diffuse large B cell lymphoma (DLBCL) with MYC rearrangement or double expression of MYC and BCL-2 (DE DLBCL) has a relatively poor prognosis and does not respond well to standard R-CHOP. In the current study, we aimed to investigate the efficacy and safety of R-split-EPOCH plus high dose m...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Peng, Wang, Yu, Chen, Cui, Yang, Hang, Nie, Man, Sun, Xiao-Qing, He, Xiao-Hua, Jiang, Wen-Qi, Li, Zhi-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7974535/
https://www.ncbi.nlm.nih.gov/pubmed/33754004
http://dx.doi.org/10.7150/jca.52958

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7974535/
https://www.ncbi.nlm.nih.gov/pubmed/33754004
http://dx.doi.org/10.7150/jca.52958

Ejemplares similares